Clinical Equipoise in COVID-19 Vaccine Candidate Trials.
作者信息
Dal-Ré Rafael
机构信息
Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
出版信息
J Clin Pharmacol. 2021 Sep;61(9):1249-1250. doi: 10.1002/jcph.1868. Epub 2021 Jul 20.
Abstract
摘要
相似文献
1
Clinical Equipoise in COVID-19 Vaccine Candidate Trials.新型冠状病毒肺炎候选疫苗试验中的临床 equipoise
J Clin Pharmacol. 2021 Sep;61(9):1249-1250. doi: 10.1002/jcph.1868. Epub 2021 Jul 20.
2
COVID-19 vaccine research and the trouble with clinical equipoise.新冠病毒疫苗研究与临床 equipoise 的问题。
Lancet. 2021 Feb 13;397(10274):576. doi: 10.1016/S0140-6736(21)00198-7. Epub 2021 Feb 1.
3
Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.继续批准在低收入和中等收入国家进行安慰剂对照的新冠疫苗试验的基本原理。
Lancet. 2021 Mar 6;397(10277):878. doi: 10.1016/S0140-6736(21)00357-3. Epub 2021 Feb 19.
4
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗（灭活，Vero 细胞）有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
5
Uses of equipoise in discussions of the ethics of randomized controlled trials of COVID-19 therapies.在讨论 COVID-19 疗法随机对照试验的伦理问题时使用均衡。
BMC Med Ethics. 2021 Oct 21;22(1):143. doi: 10.1186/s12910-021-00712-5.
6
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.临床试验中 SARS-CoV-2 疫苗的免疫原性和安全性。
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1286-1304. doi: 10.52586/5024.
7
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
8
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.在欧洲和拉丁美洲的十个国家评估 CVnCoV SARS-CoV-2 mRNA 疫苗候选物的疗效和安全性（HERALD）：一项随机、观察者设盲、安慰剂对照、2b/3 期临床试验。
Lancet Infect Dis. 2022 Mar;22(3):329-340. doi: 10.1016/S1473-3099(21)00677-0. Epub 2021 Nov 23.
9
COVID-19 vaccine trials: The use of active controls and non-inferiority studies.COVID-19 疫苗试验：活性对照和非劣效性研究的应用。
Clin Trials. 2021 Jun;18(3):335-342. doi: 10.1177/1740774520988244. Epub 2021 Feb 3.
10
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine.首次使用λ-超弦进行的计算设计及SARS-CoV-2疫苗的体内验证。
Sci Rep. 2022 Apr 19;12(1):6410. doi: 10.1038/s41598-022-09615-w.
引用本文的文献
1
Placebo control group in COVID-19 vaccine trials: context and timing matters.新冠疫苗试验中的安慰剂对照组：背景和时机很重要。
Eur J Clin Pharmacol. 2022 Mar;78(3):523-526. doi: 10.1007/s00228-021-03259-x. Epub 2021 Nov 27.
本文引用的文献
1
Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines.评估 2019 年冠状病毒病（COVID-19）疫苗的长期疗效。
Clin Infect Dis. 2021 Nov 16;73(10):1927-1939. doi: 10.1093/cid/ciab226.
2
COVID-19 vaccine research and the trouble with clinical equipoise.新冠病毒疫苗研究与临床 equipoise 的问题。
Lancet. 2021 Feb 13;397(10274):576. doi: 10.1016/S0140-6736(21)00198-7. Epub 2021 Feb 1.
3
US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.美国食品药品监督管理局在为一种新冠疫苗发布紧急使用授权后，对安慰剂对照试验采取的不稳定做法。
Vaccine. 2021 Feb 22;39(8):1180-1182. doi: 10.1016/j.vaccine.2021.01.050. Epub 2021 Jan 20.
4
Trial participants' rights after authorisation of COVID-19 vaccines.新冠疫苗获批后试验参与者的权利。
Lancet Respir Med. 2021 Apr;9(4):e30-e31. doi: 10.1016/S2213-2600(21)00044-8. Epub 2021 Jan 18.
5
The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.2019冠状病毒病疫苗试验中持续使用安慰剂的伦理问题
JAMA. 2021 Jan 19;325(3):219-220. doi: 10.1001/jama.2020.25053.
6
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.赋予 COVID-19 候选疫苗紧急使用授权：对 COVID-19 疫苗试验的影响。
Lancet Infect Dis. 2021 Apr;21(4):e103-e109. doi: 10.1016/S1473-3099(20)30923-3. Epub 2020 Dec 8.
7
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.新冠疫苗的安慰剂对照试验——我们为何仍需要它们。
N Engl J Med. 2021 Jan 14;384(2):e2. doi: 10.1056/NEJMp2033538. Epub 2020 Dec 2.
8
Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.关于 COVID-19 疫苗的早期批准和使用的伦理和科学考虑。
Ann Intern Med. 2021 Feb;174(2):258-260. doi: 10.7326/M20-7357. Epub 2020 Nov 20.
9
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.新冠疫苗的紧急使用授权——安全性和有效性随访考量
N Engl J Med. 2020 Nov 5;383(19):e107. doi: 10.1056/NEJMp2031373. Epub 2020 Oct 16.
10
Equipoise and the ethics of clinical research.equipoise与临床研究伦理
N Engl J Med. 1987 Jul 16;317(3):141-5. doi: 10.1056/NEJM198707163170304.
Zotero 插件